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Abstract: Nanotechnology plays an increasingly important role in the biomedical arena. In 
particular, magnetic nanoparticles (mNPs) have become important tools in molecular 
diagnostics, in vivo imaging and improved treatment of disease, with the ultimate aim of 
producing a more theranostic approach. Due to their small sizes, the nanoparticles can cross most 
of the biological barriers such as the blood vessels and the blood brain barrier, thus providing 
ubiquitous access to most tissues. In all biomedical applications maximum nanoparticle uptake 
into cells is required. Two promising methods employed to this end include functionalization of 
mNPs with cell-penetrating peptides to promote efficient translocation of cargo into the cell and 
the use of external magnetic fields for enhanced delivery. This study aimed to compare the effect 
of both penetratin and a static magnetic field with regards to the cellular uptake of 200 nm 
magnetic NPs and determine the route of uptake by both methods. Results demonstrated that 
both techniques increased particle uptake, with penetratin proving more cell specific. Clathrin- 
medicated endocytosis appeared to be responsible for uptake as shown via PCR and western blot, 
with Pitstop 2 (known to selectively block clathrin formation) blocking particle uptake. 
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Interestingly, it was further shown that a magnetic field was able to reverse or overcome the 
blocking, suggesting an alternative route of uptake. 
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1. Introduction 
Nanoparticles (NPs) are sub-micrometer sized particles, typically less than 500 nm [1]. Due to their 
small size they have the capability to cross the highly electrically resistant blood brain barrier as well 
as tight junctions [2]. Recent advances in nanotechnology allow functionalisation of NPs with ligands 
for various therapeutic and diagnostic applications including bio-sensing, magnetic resonance imaging 
(MRI), site-specific drug delivery, stem cell tracking and treatment of hyperthermia [3]. Several NP 
attributes contributing to these applications include: high surface area to volume ratio and high surface 
reactivity [4]. Magnetic NPs (mNPs), such as superparamagnetic iron oxide nanoparticles (Fe2O3 and 
Fe3O4), are of such a size that they are easily magnetised under an applied field, but lose their 
magnetism as soon as the magnetic field is removed (thus preventing NP aggregation), and provide an 
excellent platform for use in clinic. Currently mNPs are employed in clinic in MRI, which allows 
intra-tissue and intracellular detection.  
The major hurdle presented to cellular internalisation is the cell plasma membrane, which acts as a 
barrier to block the molecules that are usually not actively imported by cells. This selective 
permeability of the cell membrane is due to the presence of the lipid bilayer, which is interspersed with 
transmembrane proteins. The hydrophobic nature of these lipids prevents the diffusion of various polar 
solutes such as proteins and peptides across the cell membrane, leading to the prevention of 
unconstrained influx and efflux of various solutes [5].  
When contemplating NP delivery into cells, the main cell uptake routes are: (i) specific uptake, such 
as receptor-mediated endocytosis, including both clathrin- and caveolin-mediated and (ii) non-specific 
uptake, typically pinocytosis (or ‘cell drinking’) [6]. Caveolae are typically 50-100 nm sized flask- 
shaped membrane pits, formed by the inward budding of plasma membrane, that are found on the 
surfaces of smooth muscle cells, endothelial cells and fibroblasts, and are involved in clathrin-
independent endocytosis [7]. Alternatively, clathrin-dependent endocytosis is a receptor-mediated 
endocytosis, which involves the formation of plasma membrane vesicles via membrane invagination, 
containing receptors that are highly specific to the molecule being internalised. It involves the 
recruitment of the endocytic structures that are stabilized by clathrin triskelia that form the clathrin 
coat, and contain a N-terminal β-propeller domain (TD) that acts as a hub for protein-protein 
interaction [8]. 
These routes have varying degree of success as any drug or DNA cargo attached to the NP are 
ultimately localised in cytoplasmic endosomes, and are thus open to cell degradation [6]. To overcome 
this difficulty, and to further enhance the cellular uptake, NPs can be conjugated with cell penetrating 
peptides (CPPs), which are vectors employed for to enhance cell internalisation [9, 10]. CPPs are short 
peptides containing a protein transduction domain, usually confined to less than 20 amino acids, 
conferring the ability to cross the cell membrane [11]. The common structural feature of these CPPs is 
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the presence of basic or cationic amino acids, in particular lysine and arginine, conferring the 
translocation properties [12]. The first discovered CPP was the HIV transactivator of transcription (tat) 
peptide, which is a non-toxic curtailed version of the naturally existing protein [13, 14]. Dowdy et al. 
suggested in 2001 that they are basically charged [15], with 48-60 amino acid residues being mainly 
responsible for the translocation properties of the membrane [16]. Other, naturally occurring CPPs 
include the 60 amino acid homeodomain of Drosophilla Antennapedia [17, 18] and herpes simplex 
virus type 1 protein [19], both of which are able to translocate the cell membrane. The discovery of 
these natural peptides was followed by the development of various synthetic analogues of tat peptides 
such as penetratin, a peptide of 16 amino acids, derived from the DNA binding domain of the 
Antennapedia homeoprotein, which is currently the second most commonly used CPP in NP research 
after the HIV tat peptide [20]. 
In addition to the use of CPPs, the efficacy of mNP internalisation may be further enhanced by the 
use of external static magnetic fields [21] through a process termed ‘magnetofection’, which is capable 
of increasing the transfection rates to about 100 fold using extremely low concentrations of mNPs [22]. 
We have previously shown that both the use of magnetic field and penetratin increased cellular uptake 
of 500 nm NPs [23]. In addition, a recent study in our group demonstrated that when considering cells 
cultured in 3D (collagen gel culture), a magnetic field was complimentary to the use of 200 nm mNP 
functionalised with CPPs, with both together providing the optimal gel penetration and cellular uptake 
as opposed to when used alone [24]. However, the method of cell uptake in response to both penetratin 
and a static field and whether the cell indeed uses a different uptake mechanism for either, are 
unknown. 
Therefore, this paper employs two different blockers of endocytosis, Pitstop 2 and Dyngo 4a, in a 
bid to determine the cellular uptake route. Pitstop 2 impedes the receptor-mediated endocytosis by 
arresting the clathrin-coated pit dynamics at multiple stages [10], whilst Dyngo 4a is a structural 
analog of Dynasore with increased efficacy and is a potent therapeutic target, for the treatment of 
Botulism as well as various other diseases involving the dynamin-dependent uptake mechanism [25]. 
In the study herein, fluorescently tagged 200nm mNPs functionalised with a penetratin were 
introduced to monolayer fibroblast cells in the presence and absence of a magnetic field. Cell 
internalisation was quantified, and the mechanism of uptake was analysed using PCR and western blot 
(clathrin and caveolin) alongside internalisation when cultured with the specified blockers. Results 
demonstrated that while both penetratin and the field significantly increased internalisation, with the 
former proving more cell-specific, both also appeared to employ clathrin-mediated endocytosis as a 
means of uptake. It was noted that the magnetic field could overcome the specific blocking action, 
suggesting an alternative route of uptake. 
2. Experimental Section  
2.1. Nanoparticle Synthesis and Functionalisation 
For the derivatisation of 200 nm amine terminated magnetic green-fluorescence nanoparticles 
(nano-screenMAG/G-PEA) with penetratin, we adapted previously reported protocols [24,25]. Given 
that the derivatization approach requires coupling of amine terminated materials and sulfhydryl 
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containing peptides (penetratin), sulfosuccinimidyl-4-(N-maleimidomethyl)cyclohexane-1-carboxylate 
(sulfoSMCC) was used as crosslinker. Sulfo-SMCC is a heterobifunctional crosslinker containing an 
amine-reactive N-hydroxysuccinimide ester on one end and a thiol-reactive maleimide group on the 
other end. Amine-containing NPs may be activated with sulfo-SMCC to derive sulfhydryl-reactive 
maleimides, aiming conjugation with thiol-containing molecules as in the here reported case, i.e. 
activated penetratin. The following protocol describes in detail the derivatization approach used herein: 
First, amine-terminated NPs (290 µL from a 35 mg/mL stock solution) were added to freshly 
prepared ice-cold buffer-A [100 mM 2-(N-morpholino)ethanesulfonic acid (MES), 150 mM NaCl, pH 
7.2] containing the sulfoSMCC crosslinker (500 µg). The sulfoSMCC activation reaction was allowed 
to proceed for 30 min at room temperature. Then, activated NPs were magnetically precipitated, that is, 
excess crosslinker was washed out. Please, note that these magnetic NPs can be magnetically 
precipitated using a standard magnetic separator (MagnetoPURE, Chemicell). Activated NPs were 
suspended in ice-cold buffer-A containing activated penetratin, enabling coupling overnight at 4 °C. 
Uncoupled peptide was washed out by two steps of magnetic precipitation as previously described. 
Finally, peptide-derivatized NPs were dissolved in 100 mM MES, adjusting the final volume to 1 mL 
(see Table 1). 
Table 1. Chemical description of the 200 nm NPs after functionalisation with penetratin. 
The concentration of NPs in a 1 mL sample is displayed in both mg and nmoles. The molar 
ratio of mNPs to sulfo-SMCC, (which was used for amine activation) is shown. The 
concentration of penetratin in each 1 mL sample and the molar ratio of mNPs to penetratin 
is shown. 
 mNPs (mg) mNPs (nmoles)  
~ Molar 
ratio 
(mNP:sulfoS
MCC) 
Penetratin 
(nmoles) 
~ Molar 
ratio 
(mNP:Penet
ratin) 
nano-
screenMAG/
G-PEA – 200 
nm  
10 3.7  10-3 [1:310 103] 29 [1:7.8 103] 
2.2. Transmission Electron Microscopy NP Characterisation 
A 2 L drop of NP solution at a concentration of 0.1 mg/mL in milliQ H2O was dried onto a carbon 
coated grid and viewed under a Leo 912 AB TEM at 120kV, at 40,000 magnification. 
2.3. Cell Culture 
Infinity Telomerase Immortalised primary human fibroblasts (hTERT-BJ1, Clontech Laboratories, 
Inc., California, USA) were seeded on to glass coverslips (13 mm diameter) at a density of 1  104  
cells per disk in 1 mL of complete medium. The medium used was 71% Dulbecco’s Modified Eagles 
Medium (DMEM; Sigma, Dorset, UK), 17.5% Medium 199 (Sigma), 10% Fetal Bovine Serum (FBS; 
Lonza, Castleford, UK), 0.9% 100 mM sodium pyruvate (Life Technologies, Paisley, UK). The cells 
were incubated at 37 °C with a 5% CO2 atmosphere for 24 hours (for fluorescence, ICP-MS), or 5 days 
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(for q-rtPCR, Western Blotting, TEM) to ensure cell confluence. At this point cells were incubated 
with NPs for 30 minutes (0.1 mg.mL-1), unless specified otherwise, at 37 °C, 5% CO2 +/- 350 mT 
magnetic field (magnetoPLATE, Chemicell GmbH, Berlin, Germany). Control cells were cultured in 
the absence of NPs, +/- 350mT magnetic field. With regards to endocytosis blocking experiments, 
cells were incubated with both Pitstop 2Tm and Dyngo 4aTm blockers (Abcam, Ascent Scientific, 
Cambridge, UK) at the recommended concentration of 30µM for 15 min (37C, 5%CO2) prior to 
incubation with the NPs (+/- 350 mT magnetic field). Control cells were cultured in the absence of 
both Pitstop and Dyngo blockers. 
2.4. Quantification of NP Uptake into Cells: Inductively Coupled Plasma Mass Spectrometry (ICP-
MS) 
Cells were grown in a 96 well plate and then incubated with the NPs. Incubation was performed +/- 
a magnetic field, for either 1 or 18 hours. After incubation, the media from each sample was removed 
and added to 1 mL of H2O, together with 100 L PBS that had been use to wash the cells and wells. 
Samples were treated with 1 mL of 70% nitric acid (analytical reagent grade, S.G 1.42, Fisher 
Scientific, Loughborough, UK) and then heated in a water bath at 70C overnight. After heating, 
samples were cooled and then diluted to 50 mL with H2O (MilliQ H2O used throughout). Samples 
were analysed using inductively coupled plasma mass spectrometry (ICPMS; THERMO X Series II, 
Thermo Fisher Scientific, Loughborough, UK), by monitoring mass 56 in hexapole CCT ED (Collision 
Cell Technology with Energy Discrimination) mode to minimise interference from argon oxide. 
Quantification of iron using calibration solutions prepared from Spex "CertiPrep" standards diluted as 
required with 1% v/v trace element grade nitric acid (Fisher Scientific, Trace Metal Grade). 
Calibration included 6 standards in the range 0-1000 ng/mL with In-115 internal standard at 100 
ng/mL. Three replicates were collected per sample. Statistical analysis was performed in SPSS. The 
ICP-MS data for each size of mNP (100 or 200 nm), for each time point (1 or 18 hours) was analysed 
by 1-way ANOVA with Dunnett’s test [n = 3]. 
2.5. Cell Internalisation of NPs 
Cell were incubated with the NPs for 5 minutes, 30 minutes and 60 minutes at 37 °C, 5% CO2 +/- 
350 mT magnetic fields to determine uptake patterns with time in culture. Control cells were cultured 
in the absence of any NPs, +/- 350 mT magnetic field. Cells were washed with PBS, fixed with 
PBS/4% formaldehyde and washed again with PBS. 
2.5.1. Fluorescence Microscopy 
Coverslips were mounted with 4’6-diamidino-2-phenylindole (DAPI, in fluorescent mounting 
medium, Vector Laboratories Inc. Burlingame, UK) before being viewed using a Leica DM IRB 
fluorescent microscope.  
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2.5.2. Fluorescent Platereader 
The samples were washed several times in PBS prior to fluorescent detection on the ModulusTM 
Microplate Multimode Reader (Turner Biosystems, Promega, Southampton, UK) using the blue filter 
(excitation 490 nm, emission 510-570 nm), which had spectra closest to that of the NPs. 
2.6. Route of NP Internalisation 
2.6.1. Clathrin and Caveolin Real Time Polymerase Chain Reaction (q-rtPCR)  
Cells were as described on a 24 well plate and challenged with the NPs. After 1 hour, treatments 
were removed and RNA was extracted using an RNeasy Mini Kit (Qiagen). Reverse transcription was 
performed using a QuantiTect Rev. Transcription kit (Qiagen). Each qRT-PCR reaction contained 10 
ng cDNA. Three technical replicas were used for each of three biological replicas. A 7500 Realtime 
PCR System (Applied Biosystem, Life Technologies, Paisley, UK) was used, with Taqman master mix 
and Abi Prism 96-well plates as supplied by Applied Biosystems. Primers and probes for clathrin and 
caveolin and GAPDH were supplied by Eurofins MWG Operon (Germany, Europe) 
2.6.2. Western Blotting Analysis of Clathrin and Caveolin 
Following NP incubations 1 mL PBS was added per sample, samples were lysed using three 
freeze/thaw cycles of -80 °C for 20 minutes followed by 37 °C for 30 minutes. Total protein 
concentration of each sample was determined spectrophotometrically using the Nanodrop (Labtech, 
East Sussex, UK). Equal concentrations of all samples were reduced, then run on a 4-12% NuPAGE 
Novex Bis Tris Gel using the NuPage electrophoresis system, following manufacturer’s instructions. 
Proteins were then transferred to Hybond-P PVDF Membrane following manufacturer’s instructions. 
After non-specific blocking, detection of clathrin and caveolin was performed using specific antibodies 
and the ECL Western Blot System. X-ray film was exposed for 1 minute prior to developing using 
Kodak developer and fixer solutions. 
2.6.3. Transmission Electron Microscopy (TEM) 
Following magnetic NP incubation, samples were fixed using 1.5% glutaraldehyde (Sigma) 
buffered in 0.1 M sodium cacodylate (Agar Scientific, Stanstead, UK) at 4 °C for 1 hr and postfixed 
with 1% osmium tetroxide (Agar) and stained with 0.5% uranyl acetate for 60 min. Samples were then 
dehydrated through a series of ethanol concentrations (30%, 50%, 70%, 90%) up to dried absolute 
alcohol, followed by three changes in propylene oxide. Subsequently the coverslips were treated with 
1:1 propylene oxide:resin (TAAB Araldite epon resin) and incubated overnight in order to evaporate 
the propylene oxide. The next day, coverslips were embedded in pure resin and cut in ultrathin 
sections. Finally, the samples were stained with 2% methanolic uranyl acetate for five minutes and 
Reynolds lead citrate for five minutes, followed viewing under a LEOG12AB transmission electron 
microscope at 120 kV. 
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3. Results and Discussion 
3.1. NP Characterisation 
The TEM images of the NPs are shown in Figure 1. The hydrodynamic diameter of the mNPs was 
as described by Chemicell (~ 200 nm), which was confirmed via dynamic light scattering, with 
particles exhibiting an increase in particle negativity as measured by zeta potential demonstrating the 
successful attachment of penetratin [24]. The NPs appear smaller with TEM, as only the electron-
dense core is visible.  
Figure 1. TEM images of the 200 nm plain (a) and 200 nm penetratin-functionalised (b) 
NPs. [Scale bar = 100 nm]. 
 
3.2. NP Internalisation 
3.2.1. ICP-MS Analysis 
The amount of mNPs uptaken by cells was quantified by ICP-MS analysis of iron after both mNPs 
had been incubated with the cells for both 1 and 18 hours (Figure 2).  
Figure 2. Amount of NP uptake into monolayer cells. Both a magnetic field and the 
attachment of penetratin significantly increased cellular uptake of the 200 nm NPs (average 
of n = 5 +/-sd; p < 0.001 for all significant differences described in Section 3.2.1). 
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Two key significantly different observations were noted: (i) a MF increased the uptake of plain NPs 
at 1 hour compared to no MF, whereas the penetratin NPs showed no enhanced uptake with a MF (ii) 
penetratin increased the uptake of both NPs at 1 hour and 18 hours as compared to plain NPs. In 
addition it was noted that the penetratin uptake (no MF) was comparable at both time points.  
3.2.2. Fluorescence Microscopy 
Observations of particle uptake over a 60-minute time period were performed, as ICP-MS results 
indicated that, aside from the plain without a field, uptake did not increase significantly beyond that 
point (Figure 3). During the 60-minute period, several key points were noted: (i) uptake was typically 
increased in a time dependent manor, (ii) penetratin indicated higher uptake levels as compared to 
plain NPs, (iii) a magnetic field increases uptake and (v) the penetratin NPs appear to be more cell-
associated than the plain NPs (clustering around the cell nuclei). 
Figure 3. Fluorescence microscopy to identify uptake patterns over time. Uptake of both 
plain and penetratin NPs +/- magnetic field (MF) over a 60 minute incubation period for 
the 200 nm NPs (green: NPs, blue: nucleus). 
 
3.2.3. Fluorescent Platereader Analysis 
The cellular uptake of the plain and penetratin functionalised 200 nm NPs was quantified using a 
fluorescent plate-reader (Figure 4). All results described were significantly different and data 
confirmed observations in Section 3.2.2:  (i) the NP uptake increased in a time dependent manor, (ii) a 
MF increased the uptake of both NPs compared with without an MF, and  (iii) penetratin NPs were 
more efficiently internalised than plain NPs both +/- MF. 
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Figure 4. Assessment of 200 nm NP internalisation after 1 hour incubation as measured 
via fluorescent plate reader (average of n = 6 +/-sd; p < 0.001 for all significant differences 
described in Section 3.2.3). 
 
3.3. Route of Internalisation 
3.3.1. Clathrin and Caveolin qRT-PCT 
The levels of clathrin and caveolin mRNA expression were quantified by qRT-PCR after a 1 hour 
incubation with the NPs (Figure 5). In the absence of a magnetic field, while both clathrin and caveolin 
expressions were increased for the plain and penetratin, the caveolin was higher. However this trend 
was reversed in the presence of a magnetic field, where instead clathrin dominated, and a large 
decrease in caveolin was noted. 
Figure 5. Clathrin and caveolin expression as assessed by qRT-PCR, normalised to 
GAPDH (n = 3, from two experiments, +/- sd). 
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3.3.2. Clathrin and Caveolin Western Blots 
The amount of clathrin and caveolin protein were assessed by western blot after a 1 hour incubation 
with each of the NPs (Figure 6). With regards to the clathrin results, the trends for protein expression 
levels were similar to the PCR results. In the absence of a field, only the penetratin-functionalised NPs 
demonstrated a slight increase as compared to controls, however when a magnetic field was present, 
clathrin was strongly increased in both cases. Conversely, the caveolin protein expression did not 
mirror the PCR data. In this case lower caveolin levels were noted without a field, which was reversed 
in the presence of a field (the opposite of the PCR data). 
Figure 6. Clathrin and caveolin protein levels as assessed by western blotting, with band 
intensity analysed via Image J.  
 
3.4. Blocking Experiments 
3.4.1. Fluorescence Microscopy 
Cell cytoskeleton staining in control cells (without blockers) indicated a similar level of NP uptake 
both +/- a magnetic field for both the plain and penetratin NPs, where the pentratin NPs appeared more 
cell associated as compared to the random nature of the plain NPs (Figure 7, a1 and 2). Considering 
first, the absence of a magnetic field, the presence of the clathrin blocker, Pitstop, resulted in a clear 
reduction in NP uptake, with NP uptake blocked (Figure 7 b1 and b2). Dyngo also reduced NP uptake, 
although only partially, as some NPs were still observed (Figure 7 c1 and c2). 
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Figure 7. Fluoresence microscopy of plain and penetratin 200 nm particle uptake into cells 
in the absence of a magnetic field, incubated with either Pitstop or Dyngo endocytosis 
blockers. 
 
 
Interestingly, with regards to the presence of a magnetic field, blocking was evident with both the 
Pitstop and Dyngo, but only partially, as some NPs were still clearly observed (Figure 8 B1 and b2, c1 
and c2). This suggests that the magnetic field demonstrated an ability to overcome the potency of both 
blockers, Pitstop and Dyngo, signifying that either the attractive force of the magnetic field somehow interferes 
with the action of the blockers, or that NP uptake under a field is using a difference method of uptake. 
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Figure 8. Fluoresence microscopy of plain and penetratin 200 nm particle uptake into cells 
in the presence of a magnetic field, incubated with either Pitstop or Dyngo endocytosis 
blockers. 
 
3.4.2. Transmission Electron Microscopy (TEM) 
TEM was used to locate NPs uptaken into the cell body. In the absence of a field, control cells (no 
blockers) illustrated uptake of both plain and penetratin NPs through membrane invaginations resulting 
in NPs localised in vacuoles in the cytoplasm (Figure 9 a1 and a2; see annotated white arrows). When 
cells were incubated with either Pitstop of Dyngo, both the plain and penetratin NPs appeared to 
accumulate at the cell membrane, with less evidence of cellular uptake and packaging into vacuoles, 
and exhibited more membrane protrusions suggesting pinocytosis (Figure 9 b1 and b2, c1 and c2; see 
annotated black arrows).  
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Figure 9. TEM micrographs showing cellular uptake of plain and penetratin functionalised 
NPs in the absence of a magnetic field. Control cells (no blockers; a1 and a2), cells 
incubated in Pitstop (b1 and b2) and cells incubated in Dyngo (c1 and c2). Note the cell 
membrane invaginations and vacuole formations indicative of endocytosis (white arrows) 
and the membrane extrusions indicative of pinocytosis (black arrows). 
 
 
 
In the presence of a magnetic field, control cells demonstrated a higher level of NP uptake, with NP 
loaded vesicles clearly evident packaged and being processed throughout the cell cytoplasm (Figure 9 
a1 and a2). With regard to Pitstop and Dyngo, both the plain and penetratin NPs appeared to 
accumulate at the cell membrane, however in this case, there was evidence of cell membrane extensions 
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encompassing NPs (see annotated arrows in Figure 10), indicative of pinocytosis (Figure 10 b1 and b2, c1 
and c2). 
Figure 10. TEM micrographs showing cellular uptake of plain and penetratin 
functionalised NPs in the presence of a magnetic field. Control cells (no blockers; a1 and 
a2), cells incubated in Pitstop (b1 and b2) and cells incubated in Dyngo (c1 and c2). Note 
the appearance of membrane extrusions, particularly in the control cells, indicative of 
pinocytosis (black arrows). 
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3.4.3. ICP-MS 
The amount of NP uptake into the cells, under the influence of two blockers Pitstop and Dyngo, was 
quantified by ICP-MS analysis (Figure 11). Please note that the measurements are taken from the cell 
medium and normalised to control cells, thus an increase indicates a higher level of NPs in the 
medium, thus a reduction in the level entering the cells. The data reflected the blocking results 
observed in both the previous fluorescence and TEM studies, whereby a reduction in uptake was 
observed in the absence of a magnetic field, but this blocking was partially reversed in the presence of 
a field (as indicated by the negative values). 
Figure 11. Assessment of NP uptake into cells by ICP-MS levels measured in the cell 
medium and normalised to control cell cultures (n = 5 from 2 experiments,  sd).  
 
4. Conclusions  
In this study, we have demonstrated a comprehensive and comparative analysis of cellular uptake of 
plain and penetratin magnetic NPs in the presence and absence of external magnetic field. The initial 
part of the paper was designed to measure and compare total uptake into cells. Results clearly showed 
that the penetratin increased cellular uptake, as expected, and that the uptake was more cell specific 
compared to plain nanoparticles. Penetratin is a secondary amphipathic CPP that has been studied 
extensively over the last decade, and its functionalisation with NPs strongly augments the NP uptake.  
The cell association observed was most likely due to the net penetratin positive charge (due to the 
presence of abundant appropriate amino acid residues, e.g. arginine) that promotes a strong affinity 
towards the negative cell plasma membrane. This attraction would contribute to the enhancement in 
the uptake of penetratin NPs, and may also enable the ability of escaping extensive degradation by 
endosomes [26]. In addition to penetratin enhancing uptake, a magnetic field also increased NP uptake 
into cells, particularly within the first hour of culture, with little difference was noted after 18 hours in 
culture, suggesting an uptake threshold or saturation. Previous general observations showed that 
magnetic NP uptake increased in the presence of static magnetic fields, as the field physically 
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accelerates the sedimentation of mNPs on the surface of the cell [23, 27]. Indeed, this is the 
mechanism behind the commercially available ‘magnetofection’ techniques (i.e. transfecting using a 
magnetic field) [28].  
The second part of the paper was aimed at identifying the possible means of NP uptake, focusing on 
the two more established routes of uptake: clathrin- and caveolin-mediated endocytosis. Early work 
had suggested a receptor-independent pathway to be responsible for the penetratin uptake [29]. 
However subsequent studies have indicated that endocytosis in conjunction with direct translocation to 
be the actual mechanism of uptake. The presence of arginine and lysine (highly positively charged 
amino acids) play an essential part in the cell uptake of penetratin [30] alongside the presence of 
proteoglycans on the cellular surface, which are crucial for its initial interaction with the cells [31]. In 
this study, plain and penetratin NPs both demonstrated an increase in clathrin (via PCR and western 
blot), highlighting clathrin’s role is NP uptake. Unfortunately the caveolin results were contradictory, 
however with a cargo size of 200 nm, caveolin uptake is expected to be limited. 
To date, there has been little work to elucidate the cellular uptake route under the influence of a 
magnetic field, despite the frequent use in culture. Previous studies in our group using 500 nm 
magnetic NPs have suggested that an external static magnetic field may increase the cellular levels of 
clathrin, thus instigating clathrin-mediated endocytosis of the 500 nm magnetic NPs [23], whilst low 
caveolin levels were detected. This was again shown here, with 200 nm magnetic NPs, whereby 
clathrin gene and protein expression were noted higher in the presence of a field.  Brief exposure to a 
static magnetic field (15 minutes, 100 mT) has previously been shown to increase activator protein-1 
(AP-1) expression, a transcription factor that regulates gene expression in response to a variety of 
stimuli, and thus controls various cell processes including proliferation and apoptosis [32]. It may be 
that a magnetic field also influences endocytosis through such transcription factors. 
The final part of the paper was aimed at further study of the use of clathrin in the uptake of both 
plain and penetratin NPs, with and without a magnetic field by employing specific clathrin endocytosis 
blockers. Recently published data using Pitstop 2 has clearly shown its blocking impact on clathrin- 
mediated endocytosis, that selectively impede the association of endocytic ligands with the clathrin 
terminal domain which is mainly involved in the internalization of various pathogens and growth 
factors [10].  In this study, all data (fluorescent uptake, TEM and ICP-MS) indicated that Pitstop 
blocked uptake of both the plain and penetratin mNPs, confirming uptake is via clathrin-mediated 
endocytosis. 
The second blocker employed, Dyngo, is known to block dynamin, that causes the scission of the 
vesicles formed during the internalisation of NPs. Dyngo was earlier extensively studied, as an 
inhibitor of Botulinum neurotoxins, that mainly causes paralytic symptoms of the botulism, and this 
blocker has been proved to hinder the internalisation of these neurotoxins in the nerve terminals, that 
mainly enter neurons through synaptic vesicles and via clathrin-coated pits [25]. However, in this 
study, this interfering property of dyngo during endocytosis was evident to a less extent, as partial 
blocking in the uptake was observed. 
The blocking of NP uptake observed with Pitstop and Dingo was reversed under the presence of a 
magnetic field, as both the penetratin as well as plain NPs were noted in the cell (indicated by 
fluorescence, TEM and ICP-MS). This may be due to several possibilities. Data from Section 3.3 
demonstrated an increase in clathrin in the presence of a magnetic field, thus perhaps the field is 
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somehow stimulating cell clathrin synthesis to an extent whereby levels overwhelm the blockers. 
Alternatively, the strong magnetic force that pulls the NPs inside the cell may be great enough to 
totally overcome the clathrin blocking activity, by directly pulling mNPs through the cell plasma 
membrane, a theory supported by previous publications [33, 34]. A third possibility may be that the 
field is instigating a different uptake pathway, such as an increase in uptake via macropinocytosis. 
Certainly, when considering the TEM images, there was clear evidence for pinocytosis in control cells 
under a magnetic field (Figure 9a1 and a2), which was not as obvious without a field. A recently 
published study focusing on the magnetically enhanced uptake of 50 nm magnetic silica mesoporous 
NPs identified clathrin as the main route of uptake (via blocking experiments; 30 mins incubation, 
0.1T), however the blocking was also reversed under the influence of a magnetic field [35]. The 
authors surmised that the enhanced uptake observed under a field depended on the field properties, that 
the field was strong enough to essentially pull the NPs through the membrane, based on reported 
calculation of magnetic NPs begin pulled through model membranes [34]. 
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